Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pathogen-Inactivated RBCs in Pediatric Oncology/Hematology
NCT03426553Phase 3Completed
- Sponsor
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
- Start
- Jan 2018
- Primary completion
- Sep 2018
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in anemia (2 arms), sponsored by Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. Primary endpoints: Post-transfusion reactions at 24 hours, Augmentation of hemoglobin at 24 hours and 4 more. Started Jan 2018; status: completed.
02
Conditions
anemia
Beyond the preview
Go deeper on NCT03426553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03426553.